1,708 results on '"Biomedical laboratories -- Reports"'
Search Results
2. Radnet, Inc. Files SEC Form 8-K, Current Report: (Nov. 26, 2024)
3. Quest Diagnostics Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Nov. 27, 2024)
4. Psychemedics Corp. Files SEC Form 8-K, Current Report: (Nov. 25, 2024)
5. Natera, Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Nov. 25, 2024)
6. Natera, Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Nov. 26, 2024)
7. Labcorp Holdings Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Nov. 22, 2024)
8. Labcorp Holdings Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Nov. 21, 2024)
9. Fulgent Genetics, Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Nov. 25, 2024)
10. Enzo Biochem Inc. Files SEC Form 8-K, Current Report: (Nov. 25, 2024)
11. Data on Clinical Chemistry and Laboratory Medicine Published by a Researcher at Nicolaus Copernicus University in Torun (Not all biases are created equal: how to deal with bias on laboratory measurements)
12. Studies from Clinical Laboratory in the Area of Gold Nanoparticles Described (Anticancer Efficacy of Biosynthesized Zinc Oxide and Gold Nanoparticles)
13. Research in the Area of Nanoparticles Reported from Clinical Laboratory (Evaluating Antioxidant Enzyme Parameters in Rats Treated with Berberine-Loaded Bovine Serum Albumin Nanoparticles and Scopolamine)
14. Reports Outline Obstetrics and Gynecology Study Findings from Medical Laboratory Center (Clinical, cytogenetic and molecular analyses of a rare case with ring chromosome 15 and review of the literature) (Clinical, cytogenetic and molecular ...)
15. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Nov. 20, 2020)
16. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Nov. 13, 2020)
17. Miragen Therapeutics, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 12, 2020)
18. Cancer Genetics, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 12, 2020)
19. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Nov. 12, 2020)
20. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Nov. 10, 2020)
21. Data from Clinical Laboratory Provide New Insights into Experimental Autoimmune Encephalomyelitis (Amifostine ameliorates induction of experimental autoimmune encephalomyelitis: Effect on reactive oxygen species/NLRP3 pathway)
22. Reports from University of Milan Highlight Recent Findings in Laboratory Hematology [International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13]
23. Report Summarizes Ovarian Cancer Study Findings from Department of Clinical Laboratory (RBBP6 aggravates the progression of ovarian cancer by targeting PIK3R6)
24. Working Class in Bengaluru Deeply Affected by Diabetes: Metropolis Healthcare Study
25. Investigators at Center for Clinical Laboratory Report New Data on Cancer (Advances in the role of m6A RNA modification in cancer metabolic reprogramming)
26. Researchers at Department of Clinical Laboratory Discuss Findings in Breast Cancer (The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer)
27. Studies Conducted at Department of Clinical Laboratory on Breast Cancer Recently Reported (MiR-27a Facilitates Breast Cancer Progression via GSK-3b)
28. Miragen Therapeutics, Inc. Files SEC Form 8-K/A, Current Report: (Oct. 1, 2020)
29. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Oct. 5, 2020)
30. Findings on Cancer Reported by Researchers at National Cancer Center Hospital East (Impact of DNA integrity on the success rate of tissue-based next-generation sequencing: Lessons from nationwide cancer genome screening project SCRUM-Japan ...)
31. Researchers from Department of Clinical Laboratory Report Findings in Beta Thalassemia [Rare double heterozygosity for poly A(A> G) and CD17(A> T) of beta thalassemia intermedia in a Chinese family]
32. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Sept. 24, 2020)
33. Reports Outline Drug Testing and Analysis Findings from University of Utah (Evaluate the Comparability of Two Automated Liquid Handling Systems for Clinical Toxicology Assays)
34. Patent Issued for Fluid Management And Patient Monitoring System (USPTO 10,779,756)
35. New Cervical Cancer Study Findings Recently Were Reported by Researchers at Department of Clinical Laboratory (MicroRNA-150 suppresses p27Kip1 expression and promotes cell proliferation in HeLa human cervical cancer cells)
36. Department of Clinical Laboratory Researchers Add New Data to Research in Cancer (miR-19 Is a Potential Clinical Biomarker for Gastrointestinal Malignancy: A Systematic Review and Meta-analysis)
37. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Sept. 15, 2020)
38. Researchers at Tianjin Medical Laboratory Report New Data on Spinal Muscular Atrophy (NGS-based spinal muscular atrophy carrier screening of 10,585 diverse couples in China: a pan-ethnic study)
39. Reports Summarize Clinical Laboratory Analysis Findings from University of Ulsan (Performance Evaluation of an Amplicon-based Next-generation Sequencing Panel Forbrca1andbrca2variant Detection)
40. Patent Issued for Electrode Lead (USPTO 10,751,143)
41. New Findings on Bladder Cancer Discussed by Researchers at Department of Clinical Laboratory (Serum LUCAT1 implicates the pathogenesis of muscle-invasive bladder cancer via targeting miR-199a-5p and miR-199b-5p)
42. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Aug. 20, 2020)
43. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Aug. 24, 2020)
44. Cancer Genetics, Inc. Files SEC Form 8-K, Current Report: (Aug. 14, 2020)
45. Cancer Genetics, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Aug. 13, 2020)
46. Study Findings on Antifungals Are Outlined in Reports from Department of Clinical Laboratory (Management of candiduria in hospitalized patients: a single-center study on the implementation of IDSA guidelines and factors affecting clinical ...)
47. New Breast Cancer Study Findings Reported from Department of Clinical Laboratory (circCDYL Acts as a Tumor Suppressor in Triple Negative Breast Cancer by Sponging miR-190a-3p and Upregulating TP53INP1)
48. Recent Findings in Neurochemistry Described by Researchers from Department of Clinical Laboratory (EGb761 Protects Brain Microvascular Endothelial Cells Against Oxygen-Glucose Deprivation-Induced Injury Through lncRNA Rmst/miR-150 Axis)
49. Miragen Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Jul. 24, 2020)
50. Findings in Clinical Laboratory Analysis Reported from Reproductive Medicine Center (Roles of estradiol levels on the day of human chorionic gonadotrophin administration in the live birth of patients with frozen embryo transfer)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.